Strain identifier

BacDive ID: 8324

Type strain: Yes

Species: Mycobacterium smegmatis

Strain Designation: GA 735, Cornell 3, 14 133 0010

Strain history: CIP <- 1995, V. Vincent, Inst. Pasteur, Paris, France: strain 14 133 0010 <- 1981, ATCC <- NCTC <- R.E. Gordon <- Hagan <- Alvarez and Tavel: strain Cornell 3

NCBI tax ID(s): 1772 (species)

« Browse strain by BacDive ID »

expand / minimize allblue arrow down

Exclude non-curated data/information

Mycobacterium smegmatis GA 735 is an aerobe, mesophilic, Gram-positive human pathogen of the family Mycobacteriaceae.

  1. Gram-positive
  2. aerobe
  3. human pathogen
  4. mesophilic
  5. 16S sequence
  6. Bacteria
  7. genome sequence
  • Availability in culture collections External linksarrow_down
  • [Ref.: #11178] Culture collection no. DSM 43756, ATCC 19420, JCM 5866, KCTC 9108, NCTC 8159, CCUG 21002, CCUG 21815, CECT 3020, CIP 104444, JCM 6386, NRRL B-14616, VKM Ac-1239
    [Ref.: #77726] *
    Literature: Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries.
    Topicarrow to sort Titlearrow to sort Authorsarrow to sort Journalarrow to sort DOIarrow to sort Yeararrow to sort
    Enzymology Crystal structure and biochemical characterization of O-acetylhomoserine acetyltransferase from Mycobacterium smegmatis ATCC 19420. Sagong HY, Hong J, Kim KJ Biochem Biophys Res Commun 10.1016/j.bbrc.2019.07.117 2019 *
    Pathogenicity New quinolin-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines as potential antitubercular agents. Thomas KD, Adhikari AV, Chowdhury IH, Sumesh E, Pal NK Eur J Med Chem 10.1016/j.ejmech.2011.03.039 2011 *
    Genetics A rifampin-hypersensitive mutant reveals differences between strains of Mycobacterium smegmatis and presence of a novel transposon, IS1623. Alexander DC, Jones JR, Liu J Antimicrob Agents Chemother 10.1128/AAC.47.10.3208-3213.2003 2003 *
    Enzymology Panniculitis, due to Mycobacterium smegmatis, in two Finnish cats. Alander-Damsten YK, Brander EE, Paulin LG J Feline Med Surg 10.1053/jfms.2001.0189 2003 *
    Pathogenicity Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes. Naas T, Mikami Y, Imai T, Poirel L, Nordmann P J Bacteriol 10.1128/JB.183.1.235-249.2001 2001 *
    Metabolism Structures of ADP-ribosylated rifampicin and its metabolite: intermediates of rifampicin-ribosylation by Mycobacterium smegmatis DSM43756. Morisaki N, Hashimoto Y, Furihata K, Imai T, Watanabe K, Mikami Y, Yazawa K, Ando A, Nagata Y, Dabbs ER J Antibiot (Tokyo) 10.7164/antibiotics.53.269 2000 *
    Metabolism Identification and characterization of a new intermediate in the ribosylative inactivation pathway of rifampin by Mycobacterium smegmatis. Imai T, Watanabe K, Mikami Y, Yazawa K, Ando A, Nagata Y, Morisaki N, Hashimoto Y, Furihata K, Dabbs ER Microb Drug Resist 10.1089/mdr.1999.5.259 1999 *
    Phylogeny Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Brown BA, Springer B, Steingrube VA, Wilson RW, Pfyffer GE, Garcia MJ, Menendez MC, Rodriguez-Salgado B, Jost KC Jr, Chiu SH, Onyi GO, Bottger EC, Wallace RJ Jr Int J Syst Bacteriol 10.1099/00207713-49-4-1493 1999 *
    Enzymology Pathogenicity of Mycobacterium fortuitum and Mycobacterium smegmatis to goldfish, Carassius auratus. Talaat AM, Trucksis M, Kane AS, Reimschuessel R Vet Microbiol 10.1016/s0378-1135(99)00002-4 1999 *
    Metabolism ADP-ribosylation as an intermediate step in inactivation of rifampin by a mycobacterial gene. Quan S, Imai T, Mikami Y, Yazawa K, Dabbs ER, Morisaki N, Iwasaki S, Hashimoto Y, Furihata K Antimicrob Agents Chemother 10.1128/AAC.43.1.181 1999 *

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Field you want to change:


CAPTCHAReload captcha

Change proposal

Successfully sent